Kimberly Chong

Array ( [id] => 10912955 [patent_doc_number] => 20140315973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'PARP-1 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/877972 [patent_app_country] => US [patent_app_date] => 2011-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 36560 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9944233 [patent_doc_number] => 08993533 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-31 [patent_title] => 'Treatment of sialidase 4 (NEU4) related diseases by inhibition of natural antisense transcript to NEU4' [patent_app_type] => utility [patent_app_number] => 13/879100 [patent_app_country] => US [patent_app_date] => 2011-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25964 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13879100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9069411 [patent_doc_number] => 20130261167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-03 [patent_title] => 'ANCCA as a Diagnostic Biomarker and Therapeutic Target for Breast Cancers' [patent_app_type] => utility [patent_app_number] => 13/825309 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 31272 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8977470 [patent_doc_number] => 20130210901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'METHOD OF TREATING NEURODEGENERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 13/825131 [patent_app_country] => US [patent_app_date] => 2011-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18977 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10831350 [patent_doc_number] => 08859519 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-14 [patent_title] => 'Methods targeting miR-33 microRNAs for regulating lipid metabolism' [patent_app_type] => utility [patent_app_number] => 13/818590 [patent_app_country] => US [patent_app_date] => 2011-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 17 [patent_no_of_words] => 17919 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13818590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7657248 [patent_doc_number] => 20110306517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'REDUCING IRF4, DUSP22, OR FLJ43663 POLYPEPTIDE EXPRESSION' [patent_app_type] => utility [patent_app_number] => 13/213390 [patent_app_country] => US [patent_app_date] => 2011-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 15591 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306517.pdf [firstpage_image] =>[orig_patent_app_number] => 13213390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11205329 [patent_doc_number] => 09434949 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-06 [patent_title] => 'Uses of the human ZFX gene and drugs associated with same' [patent_app_type] => utility [patent_app_number] => 14/239120 [patent_app_country] => US [patent_app_date] => 2011-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 8186 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14239120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8772622 [patent_doc_number] => 08426579 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'SiRNA targeting myeloid differentiation primary response gene (88) (MYD88)' [patent_app_type] => utility [patent_app_number] => 13/136812 [patent_app_country] => US [patent_app_date] => 2011-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34871 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13136812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9086090 [patent_doc_number] => 08557516 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-15 [patent_title] => 'AKT tyrosine 176 phosphorylation cancer biomarker' [patent_app_type] => utility [patent_app_number] => 13/205171 [patent_app_country] => US [patent_app_date] => 2011-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 51 [patent_no_of_words] => 16782 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13205171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8549489 [patent_doc_number] => 08324371 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Oligomers' [patent_app_type] => utility [patent_app_number] => 13/204326 [patent_app_country] => US [patent_app_date] => 2011-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17759 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13204326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9206072 [patent_doc_number] => 20140005249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'NKX2.2 INHIBITORS AS DRUGS' [patent_app_type] => utility [patent_app_number] => 13/811461 [patent_app_country] => US [patent_app_date] => 2011-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8611 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13811461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9003112 [patent_doc_number] => 20130224237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'INHIBITION OF NONSENSE MEDIATED DECAY PATHWAYS' [patent_app_type] => utility [patent_app_number] => 13/810808 [patent_app_country] => US [patent_app_date] => 2011-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 25733 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9212683 [patent_doc_number] => 20140011860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'COMPOUNDS AND METHODS FOR MODULATING TARGET NUCLEAR AND SUB-NUCLEAR NUCLEIC ACID MOLECULES IN CELLS AND ANIMALS' [patent_app_type] => utility [patent_app_number] => 13/811248 [patent_app_country] => US [patent_app_date] => 2011-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 30470 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13811248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10169582 [patent_doc_number] => 09200286 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-01 [patent_title] => 'Subunit-selective nucleic acid inhibitors of glutamate receptors' [patent_app_type] => utility [patent_app_number] => 13/810572 [patent_app_country] => US [patent_app_date] => 2011-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13481 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8128741 [patent_doc_number] => 20120088907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'OLIGOMERIC COMPOUNDS FOR THE MODULATION OF SURVIVIN EXPRESSION' [patent_app_type] => utility [patent_app_number] => 13/183365 [patent_app_country] => US [patent_app_date] => 2011-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 37200 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20120088907.pdf [firstpage_image] =>[orig_patent_app_number] => 13183365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7651955 [patent_doc_number] => 20110301224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA' [patent_app_type] => utility [patent_app_number] => 13/178844 [patent_app_country] => US [patent_app_date] => 2011-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13052 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301224.pdf [firstpage_image] =>[orig_patent_app_number] => 13178844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9662536 [patent_doc_number] => 08809515 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-19 [patent_title] => 'Methods and compositions for the specific inhibition of gene expression by double-stranded RNA' [patent_app_type] => utility [patent_app_number] => 13/178806 [patent_app_country] => US [patent_app_date] => 2011-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 35 [patent_no_of_words] => 22954 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13178806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7567027 [patent_doc_number] => 20110287090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'Compositions and Methods for Inhibiting Expression of a Mutant Gene' [patent_app_type] => utility [patent_app_number] => 13/177316 [patent_app_country] => US [patent_app_date] => 2011-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10259 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20110287090.pdf [firstpage_image] =>[orig_patent_app_number] => 13177316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9626763 [patent_doc_number] => 08796444 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-05 [patent_title] => 'Methods and compositions for the specific inhibition of gene expression by double-stranded RNA' [patent_app_type] => utility [patent_app_number] => 13/177051 [patent_app_country] => US [patent_app_date] => 2011-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 35 [patent_no_of_words] => 22969 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13177051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9958211 [patent_doc_number] => 09006417 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-14 [patent_title] => 'Non-liposomal systems for nucleic acid delivery' [patent_app_type] => utility [patent_app_number] => 13/807288 [patent_app_country] => US [patent_app_date] => 2011-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 71555 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13807288 [rel_patent_id] =>[rel_patent_doc_number] =>)